Hideki Maki

1.2k total citations
52 papers, 828 citations indexed

About

Hideki Maki is a scholar working on Infectious Diseases, Molecular Biology and Language and Linguistics. According to data from OpenAlex, Hideki Maki has authored 52 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 14 papers in Molecular Biology and 12 papers in Language and Linguistics. Recurrent topics in Hideki Maki's work include Antimicrobial Resistance in Staphylococcus (13 papers), Syntax, Semantics, Linguistic Variation (10 papers) and Antibiotic Resistance in Bacteria (9 papers). Hideki Maki is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (13 papers), Syntax, Semantics, Linguistic Variation (10 papers) and Antibiotic Resistance in Bacteria (9 papers). Hideki Maki collaborates with scholars based in Japan, United Kingdom and Switzerland. Hideki Maki's co-authors include Kazuhisa Murakami, Yoshinori Yamano, Kenji Miura, Takahiro Yamaguchi, Akihito Wada, Nadine McCallum, Brigitte Berger‐Bächi, Markus Bischoff, Takafumi Sato and Naoki Kohira and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Hideki Maki

43 papers receiving 788 citations

Peers

Countries citing papers authored by Hideki Maki

Since Specialization

Citations

This map shows the geographic impact of Hideki Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Maki more than expected).

Fields of papers citing papers by Hideki Maki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Maki. The network helps show where Hideki Maki may publish in the future.

Co-authorship network of co-authors of Hideki Maki

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Maki. A scholar is included among the top collaborators of Hideki Maki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Maki. Hideki Maki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P-1086. COT-832, a Novel Polyene Macrolide Antifungal (I): In Vitro Antifungal Activity against Candida, Aspergillus, and Mucor, etc., Hemolytic Activity, and Cytotoxicity 2025 ·Open Forum Infectious Diseases ·Hideki Maki, (unknown), Takafumi Ohara, Hideki Sugimoto	0
2	Novel humanized anti-PcrV monoclonal antibody COT-143 protects mice from lethal Pseudomonas aeruginosa infection via inhibition of toxin translocation by the type III secretion system 2024 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), Yosuke Okuno, Yasuhiko Sato, Shoji Yamane, Hideki Maki, Takafumi Sato, Yoshinori Yamano	2
3	Neural underpinning of Japanese particle processing in non-native speakers 2022 ·Scientific Reports ·(unknown), Motofumi Sumiya, Takahiko Koike, (unknown), Hideki Maki, Norihiro Sadato	2
4	A highly sensitive and specific method to evaluate viable fungal burden of Aspergillus fumigatus in mice by RT-qPCR for 18S ribosomal RNA 2021 ·Journal of Microbiological Methods ·(unknown), (unknown), Ken‐ichi Okazaki, Hideki Maki, Akira Naito	1
5	Discovery of 2-Sulfinyl-Diazabicyclooctane Derivatives, Potential Oral β-Lactamase Inhibitors for Infections Caused by Serine β-Lactamase-Producing Enterobacterales 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Hiroki Kusano, Soichiro Sato, Toshiaki Aoki, Naoki Kohira, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hideki Maki, Kenji Yamawaki	8
6	Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014) 2020 ·Journal of Global Antimicrobial Resistance ·Naoki Kohira, Meredith Hackel, (unknown), (unknown), Daniel F. Sahm, Takafumi Sato, Hideki Maki, Yoshinori Yamano	84
7	Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria 2020 ·Journal of Medicinal Chemistry ·Kouhei Matsui, Yukiko Kan, Junko Kikuchi, (unknown), Miki Takemura, Hideki Maki, (unknown), (unknown), Kazuyuki Minagawa	17
8	Anti-PcrV titers in non-cystic fibrosis patients with Pseudomonas aeruginosa respiratory tract infection 2019 ·International Journal of Infectious Diseases ·Kentaro Nagaoka, Yu Yamashita, Hirokazu Kimura, Hiroki Kimura, Masaru Suzuki, Tatsuya Fukumoto, Kasumi Hayasaka, Mari Yoshida, (unknown), Hideki Maki, (unknown), Satoshi Konno	4
9	Screening for FtsZ Dimerization Inhibitors Using Fluorescence Cross-Correlation Spectroscopy and Surface Resonance Plasmon Analysis 2015 ·PLoS ONE ·Shintaro Mikuni, Kota Kodama, Akira Sasaki, Naoki Kohira, Hideki Maki, Masaharu Munetomo, Katsumi Maenaka, Masataka Kinjo	11
10	Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli 2015 ·Journal of Infection and Chemotherapy ·Tsukasa Horiyama, (unknown), (unknown), (unknown), Takafumi Sato, Takahiro Yamaguchi, Masakatsu Tsuji, Hideki Maki	2
11	Acquisition of the Wh-interrogativeConstruction by Japanese Junior High School EFL Learners 2014 ·(unknown), Hideki Maki	0
12	Staphylococcus aureus Penicillin‐Binding Protein 2 Can Use Depsi‐Lipid II Derived from Vancomycin‐Resistant Strains for Cell Wall Synthesis 2013 ·Chemistry - A European Journal ·Jun Nakamura, (unknown), (unknown), Kenzo Nishiguchi, Hideki Maki, Hirokazu Arimoto	7
13	Two Types of Asymmetries in Acquisition of the Wh-Interrogative Construction by Japanese ESL Learners 2012 ·(unknown), Hideki Maki, (unknown)	1
14	The Minimal English Test: a new method to measure English as a Second Language proficiency 2010 ·Evaluation & Research in Education ·Kenichi Gotō, Hideki Maki, (unknown)	8
15	Staphylococcus aureus MurC Participates in L-Alanine Recognition via Histidine 343, a Conserved Motif in the Shallow Hydrophobic Pocket 2007 ·The Journal of Biochemistry ·Kazuo Kurokawa, Satoshi Nishida, (unknown), Hikaru Mizumura, Kensuke Ueno, Takashi Yutsudo, Hideki Maki, Kazuhisa Murakami, Kazuhisa Sekimizu	9
16	Isolation and mutation site determination of the temperature-sensitivemurBmutants ofStaphylococcus aureus 2003 ·FEMS Microbiology Letters ·Miki Matsuo, Kenji Kurokawa, Satoshi Nishida, Yan Li, (unknown), Chikara Kaito, Norio Fukuhara, Hideki Maki, Kenji Miura, Kazuhisa Murakami, Kazuhisa Sekimizu	26
17	Exceptional Case Marking(ECM) Constructions in Japanese: A Preliminary Study 2001 ·Keiichiro Kobayashi, Hideki Maki	1
18	Katanosin B and Plusbacin A ₃ , Inhibitors of Peptidoglycan Synthesis in Methicillin-Resistant Staphylococcus aureus 2001 ·Antimicrobial Agents and Chemotherapy ·Hideki Maki, Kenji Miura, Yoshinori Yamano	78
19	Formation of potent hybrid promoters of the mutant llm gene by IS256 transposition in methicillin-resistant Staphylococcus aureus 1997 ·Journal of Bacteriology ·Hideki Maki, Kazuhisa Murakami	51
20	The syntax of particles 1995 ·UMI Dissertation Services eBooks ·Hideki Maki	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact